Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CARDINAL HEALTH, INC.

(CAH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sector Update: Health Care Stocks Slip In Thursday Markets

05/06/2021 | 04:12pm EDT


ę MT Newswires 2021
All news about CARDINAL HEALTH, INC.
08/03Cardinal Health Partners with Chronicled to Enhance Pharmaceutical Chargeback..
CI
08/02CARDINAL HEALTH : Completes $1 Billion Sale of Cordis Business to Hellman & Frie..
MT
08/02CARDINAL HEALTH : completes sale of Cordis business to Hellman & Friedman
PR
08/02Hellman & Friedman LLC completed the acquisition of Cordis Corporation from C..
CI
07/28CARDINAL HEALTH : Trial against opioid distributors wraps up in West Virginia
AQ
07/27W. Va. city, drug distributors trade final words in landmark opioid trial
RE
07/27AMERISOURCEBERGEN : Closing arguments held in West Virginia lawsuit over opioids
AQ
07/27Frontline advocates view $26 billion opioid deal with frustration, worry
RE
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22CARDINAL HEALTH : DISTRIBUTORS ANNOUNCE PROPOSED OPIOID SETTLEMENT AGREEMENT (Fo..
PU
More news
Financials (USD)
Sales 2021 160 B - -
Net income 2021 652 M - -
Net Debt 2021 3 091 M - -
P/E ratio 2021 26,7x
Yield 2021 3,33%
Capitalization 17 113 M 17 113 M -
EV / Sales 2021 0,13x
EV / Sales 2022 0,11x
Nbr of Employees 48 000
Free-Float 88,8%
Chart CARDINAL HEALTH, INC.
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 59,03 $
Average target price 62,08 $
Spread / Average Target 5,16%
EPS Revisions
Managers and Directors
Michael C. Kaufmann Chief Executive Officer & Director
Jason M. Hollar Chief Financial Officer
Gregory B. Kenny Independent Non-Executive Chairman
Brian S. Rice Chief Information Officer & Executive VP
Jessica L. Mayer Chief Compliance & Legal Officer
Sector and Competitors